CADTH has received a drug submission from Boehringer Ingelheim for Spiriva Respimat (tiotropium bromide monohydrate).

 For information about the patient input process or for additional instructions, please see the Patient Input page of the CADTH website. Note that only patient groups may submit input.

For more details, go to: http://www.cadth.ca/en/products/cdr/patient-group-input-form/392